Curing with Sound cover art

Curing with Sound

Curing with Sound

Written by: Focused Ultrasound Foundation
Listen for free

About this listen

Imagine harnessing the power of sound waves to heal the human body–this isn’t science fiction, it’s the reality of focused ultrasound technology. Join the conversation that explores the transformative power of this noninvasive therapy revolutionizing the treatment of nearly 180 diseases and medical conditions and giving hope to patients worldwide. Presented by the Focused Ultrasound Foundation.Copyright 2024 All rights reserved. Hygiene & Healthy Living Physical Illness & Disease Science
Episodes
  • Ep45: Neuromodulation for Treatment-Resistant Depression with Jean-François Aubry, PhD
    Jan 13 2026

    In this episode of Curing with Sound, we speak with Dr. Jean-François Aubry, Director of Research at France's National Center for Scientific Research and a leading expert in therapeutic ultrasound with over two decades of experience in the field. Dr. Aubry discusses transcranial ultrasound stimulation (TUS), an emerging neuromodulation approach that enables precise targeting of deep brain structures without surgery, opening new avenues for treating some of the most challenging neurological and psychiatric disorders.

    He also shares compelling findings from his recent clinical trial evaluating the safety of TUS for drug-resistant depression, in which 80% of patients responded to the treatment, highlighting the potential of ultrasound neuromodulation as a noninvasive therapeutic approach.

    Discussion highlights:

    • Focused Ultrasound Center of Excellence: Dr. Aubry is the Scientific Director of the Focused Ultrasound Center of Excellence at Physics for Medicine Paris. The laboratory’s mission is to invent innovative technologies for medical imaging and therapy, providing patients and clinicians with ultrasound-based therapies as a noninvasive alternative to surgical procedures.
    • Depression Treatment Breakthrough: Dr. Aubry is a co-founder of Sonomind, a company dedicated to tackling drug-resistant depression and other neuropsychiatric disorders. The company’s personalized transcranial neuromodulation system enables noninvasive targeting of deep brain regions with unprecedented precision.

    EPISODE TRANSCRIPT

    ---------------------------- QUESTIONS? Email podcast@fusfoundation.org if you have a question or comment about the show, or if you would you like to connect about future guest appearances.

    Email info@fusfoundation.org if you have questions about focused ultrasound or the Foundation.

    FUSF SOCIAL MEDIA

    • LinkedIn
    • X
    • Facebook
    • Instagram
    • TikTok
    • YouTube

    FUSF WEBSITE https://www.fusfoundation.org SIGN UP FOR OUR FREE NEWSLETTER https://www.fusfoundation.org/newsletter-signup/ READ THE LATEST NEWSLETTER https://www.fusfoundation.org/the-foundation/news-media/newsletter/ DOWNLOAD "THE TUMOR" BY JOHN GRISHAM (FREE E-BOOK) https://www.fusfoundation.org/read-the-tumor-by-john-grisham/

    Show More Show Less
    17 mins
  • Ep44: Expanding Focused Ultrasound Across Europe with Pascale Broks
    Dec 16 2025

    Launched in 2024, the European Union Focused Ultrasound Foundation (EUFUSF) is the newest sister organization of the Focused Ultrasound Foundation, established to build and strengthen partnerships that expand the reach and impact of focused ultrasound across Europe.

    In this episode of Curing with Sound, we speak with Pascale Broks, the Foundation’s Development Director for Europe, who is spearheading the expansion of this transformative technology across the European Union. With over 25 years of experience in development and relationship management, Pascale brings a global perspective and deep passion for connecting people with purpose, driving innovation, and making focused ultrasound accessible to patients from Finland to Greece.

    Discussion highlights:

    • European Foundation Launch and Strategy: Discover the mission and vision of the newly established EUFUSF, including its distinctive approach to donor engagement, its patient-centered guiding principle, and its goal of making focused ultrasound widely recognized and accessible across Europe.

    EU FUSF Website

    EPISODE TRANSCRIPT

    ---------------------------- QUESTIONS? Email podcast@fusfoundation.org if you have a question or comment about the show, or if you would you like to connect about future guest appearances.

    Email info@fusfoundation.org if you have questions about focused ultrasound or the Foundation.

    FUSF SOCIAL MEDIA

    • LinkedIn
    • X
    • Facebook
    • Instagram
    • TikTok
    • YouTube

    FUSF WEBSITE https://www.fusfoundation.org SIGN UP FOR OUR FREE NEWSLETTER https://www.fusfoundation.org/newsletter-signup/ READ THE LATEST NEWSLETTER https://www.fusfoundation.org/the-foundation/news-media/newsletter/ DOWNLOAD "THE TUMOR" BY JOHN GRISHAM (FREE E-BOOK) https://www.fusfoundation.org/read-the-tumor-by-john-grisham/

    Show More Show Less
    12 mins
  • Ep43: Focused Ultrasound Breakthrough for Brain Cancer: A Conversation with Graeme Woodworth, MD
    Dec 2 2025

    The blood-brain barrier (BBB), while essential for protecting the brain from toxins, has long been one of the greatest obstacles in treating brain diseases, particularly aggressive cancers like glioblastoma. Most chemotherapy drugs simply cannot reach the brain in effective concentrations, leaving patients with limited treatment options and poor outcomes.

    In this episode of Curing with Sound, we speak with Graeme Woodworth, MD, Chair of the Department of Neurosurgery at the University of Maryland School of Medicine, whose work is transforming the landscape of brain tumor treatment through the use of focused ultrasound–mediated BBB opening. Dr. Woodworth discusses the role of microbubbles, his efforts to develop a real-time monitoring and dosing strategy for BBB opening, and the exciting results from his multicenter glioblastoma clinical trial.

    Discussion highlights:

    • Glioblastoma Clinical Trial: Results published in Lancet Oncology report, for the first time, a possible survival benefit among newly diagnosed glioblastoma (GBM) patients treated with focused ultrasound + temozolomide (or TMZ, a chemotherapy drug). Researchers used focused ultrasound to noninvasively open the BBB in GBM patients before administering TMZ. When compared with a matched control group, a 40% increase in overall survival was observed.
    • Published Findings for Measuring and Predicting BBB Opening: Researchers established a real-time, ultrasound-based “dose” measurement—using acoustic emissions from microbubble oscillations—to accurately predict when focused ultrasound will open the blood-brain barrier in glioblastoma patients. They discovered a non-linear dose–response range where blood-brain barrier opening is maximized, enabling safer, more precise, and more effective treatment monitoring.

    EPISODE TRANSCRIPT

    ---------------------------- QUESTIONS? Email podcast@fusfoundation.org if you have a question or comment about the show, or if you would you like to connect about future guest appearances.

    Email info@fusfoundation.org if you have questions about focused ultrasound or the Foundation.

    FUSF SOCIAL MEDIA

    • LinkedIn
    • X
    • Facebook
    • Instagram
    • TikTok
    • YouTube

    FUSF WEBSITE https://www.fusfoundation.org SIGN UP FOR OUR FREE NEWSLETTER https://www.fusfoundation.org/newsletter-signup/ READ THE LATEST NEWSLETTER https://www.fusfoundation.org/the-foundation/news-media/newsletter/ DOWNLOAD "THE TUMOR" BY JOHN GRISHAM (FREE E-BOOK) https://www.fusfoundation.org/read-the-tumor-by-john-grisham/

    Show More Show Less
    22 mins
No reviews yet